Home > In process > Editorial: Novel rehabilitation approaches for non-communicable diseases in the era of precision medicine. > print

001     285362
005     20260226162911.0
024 7 _ |a 10.3389/fmed.2026.1796605
|2 doi
024 7 _ |a pmid:41737377
|2 pmid
024 7 _ |a pmc:PMC12926400
|2 pmc
037 _ _ |a DZNE-2026-00227
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Fernandes, Júlio Belo
|b 0
245 _ _ |a Editorial: Novel rehabilitation approaches for non-communicable diseases in the era of precision medicine.
260 _ _ |a Lausanne
|c 2026
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1772119661_7490
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a adaptive interventions
|2 Other
650 _ 7 |a artificial intelligence (AI)
|2 Other
650 _ 7 |a digital health (eHealth)
|2 Other
650 _ 7 |a functional recovery
|2 Other
650 _ 7 |a non-communicable diseases (NCD)
|2 Other
650 _ 7 |a precision medicine and genomics
|2 Other
650 _ 7 |a precision rehabilitation
|2 Other
650 _ 7 |a rehabilitation
|2 Other
700 1 _ |a Outeiro, Tiago F.
|0 P:(DE-2719)2814138
|b 1
|u dzne
700 1 _ |a Baixinho, Cristina Lavareda
|b 2
700 1 _ |a Godinho, Catarina
|b 3
773 _ _ |a 10.3389/fmed.2026.1796605
|g Vol. 13, p. 1796605
|0 PERI:(DE-600)2775999-4
|p 1796605
|t Frontiers in medicine
|v 13
|y 2026
|x 2296-858X
856 4 _ |u https://pub.dzne.de/record/285362/files/DZNE-2026-00227.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/285362/files/DZNE-2026-00227.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2814138
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT MED-LAUSANNE : 2022
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2025-05-13T11:23:55Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2025-05-13T11:23:55Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2025-05-13T11:23:55Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2025-05-13T11:23:55Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-11-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-05
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-11-05
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-11-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-11-05
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21